Brazil Regulations
Federal Republic of Brazil
STATUS: ON HOLD
Authority: Brazilian Health Regulatory Authority (ANVISA)
Request Source: Regulation
Data Carrier: –
Detail: Brazilian Health Regulatory Board, ANVISA regulates the practice of pharmaceutical traceability in Brazil. All pharma manufacturers involved in the supply chain must comply with the regulations of the National System for Drug Control (SNCM). ANVISA has adopted GS1 standards in serialization applications. Although the pilot projects for the serialization application have been successfully completed, the implementation date has been determined as 2022, but there is a possibility that it will be postponed to a later date.
- GTIN
- ANVISA Registration No
- Serial Number
- Batch/Lot
- Expiry Date
Update: On May 11, 2022, according to the new regulation approved by the President, there will be no requirement about traceability, also ANVISA will not impose any sanctions on this issue. Information that has to be on the packaging:
- Serial Number
- Batch Number
- Expiry date
- 2D Barcode*
*This code will redirect to a web page with prospectus information.
Links:
https://www.gov.br/anvisa/pt-br/english
https://in.gov.br/en/web/dou/-/lei-n-14.338-de-11-de-maio-de-2022-399315842

Related Blogs
The Updated Decision on Brazil Traceability Timeline
Pharmaceutical traceability studies started in 2009 in Brazil, got on with the complementation of the pilot in 2019. [...]
Read MoreOct
Implementation of Brazilian Pharmaceutical Traceability – SNCM
Pharmaceutical traceability in Brazil started with the promulgation of law 11.903 in 2009, which defines the national pharmaceutical [...]
Read MoreAug
Home | Info Point | Regulations